Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today its participation in a presentation and panel at Innovate Retina 2024 on October 17, 2024, in Chicago, Illinois. Presentation and Panel details are below: — Presentation Title: Update on […]
The CDK4/6 inhibitors market is expected to grow significantly in the coming years. This is mainly due to the increasing incidence of HR+/HER2 breast cancer, the type for which CDK4/6 inhibitors are majorly prescribed.CDK4/6 inhibitors are now an established class, with all three approved CDK4/6 inhibitors reaching blockbuster status. An increasing number of emerging therapies
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi
Report with market evolution powered by AI – The GlobalGroundfish Marketsize is estimated to grow by USD 13.04 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.92% during the forecast period. Growing awareness about health benefits of groundfishis driving market growth,with a trend towardsgrowth of sustainable fishing
DENVER, Oct. 14, 2024 (GLOBE NEWSWIRE) — ArrowMark Financial Corp., (NASDAQ: BANX) (“ArrowMark Financial”), today announced that BANX’s estimated and unaudited Net Asset Value (“NAV”) as of September 30, 2024, was $21.73. This estimated NAV is not a comprehensive statement of our financial condition or results for the month ended September 30, 2024. About ArrowMark
Morris Plains, NJ, Oct. 14, 2024 (GLOBE NEWSWIRE) — One of the cornerstones of safety in aviation is that it isn’t a state but rather a practice. How stakeholders manage safety on an ongoing basis is essential. Of course, maintaining a consistent focus on preventing injuries, property damage and other negative events isn’t easy. That
SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased or otherwise acquired iLearningEngines, Inc. (NASDAQ: AILE) securities between April 22, 2024 and August 28, 2024. iLearningEngines purports to be an “AI-powered learning automation” software company. For
NEWTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Tri-City Healthcare District (“Tri-City”). Tri-City learned of suspicious activity on or about September 27, 2024. To join this case, go HERE. About Tri-City Healthcare District Tri-City is a regional healthcare district in
Natus Medical Incorporated’s innovation in ICU solutions will be on display Oct. 14-18, in San Diego when the leader in neurocritical care technologies participates in the 22nd Annual Neurocritical Care Society (NCS) Conference. https://mma.prnewswire.com/media/2477077/Natus_Logo.jpg The highly anticipated point-of-care EEG system complements Natus’ robust and reliable portfolio of ICU solutions While neurologists and ICU doctors eagerly
SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), have until December 13, 2024 to seek appointment as lead plaintiff of the Edwards Lifesciences class action